InspireMD Advances Embolic Protection Stent Technology
Executive Summary
InspireMD Inc. is making progress with its proprietary emboli-trapping InspireMD Embolic Protection Stent (EPS) platform technology for use primarily in patients with embolic-risk acute coronary syndromes, such as myocardial infarction and saphenous vein graft coronary interventions.